Literature DB >> 30605974

[Strategies of primary prevention of liver cancer in China: expert consensus (2018)].

.   

Abstract

Liver cancer is one of the most common cancers in China. The major risk factors are chronic infections of hepatitis B virus (HBV), hepatitis C virus (HCV), high exposure to aflatoxins. In addition, exposure to cyanotoxins and some preventable health behaviors are also recognized to contribute to liver cancer development. To relieve the disease burden, primary prevention of etiological interventions is an important strategy. Based on the liver cancer epidemiology in China and the effective evidences and results from the etiological interventions conduced in Chinese population domestically, the following strategies are recommended in the "Strategies of primary prevention of liver cancer: Expert Consensus (2018)" to promote the effective prevention of liver cancer in general population. Immunization with HBV vaccines, including the immune programs to neonates, infants and children born to mothers with different status of HBV infection. Antiviral therapies to the patients with chronic hepatitis B or hepatitis C. Avoiding or reducing the exposure to aflatoxins as well as the cyanotoxins. Changing harmful life style, including quitting smoking and limiting alcohol consumption etc.

Entities:  

Keywords:  Expert consensus; Liver neoplasms; Primary prevention

Mesh:

Year:  2019        PMID: 30605974     DOI: 10.3760/cma.j.issn.0253-3766.2018.07.013

Source DB:  PubMed          Journal:  Zhonghua Yu Fang Yi Xue Za Zhi        ISSN: 0253-9624


  4 in total

1.  Tiliroside as a CAXII inhibitor suppresses liver cancer development and modulates E2Fs/Caspase-3 axis.

Authors:  Rui Han; Hongxing Yang; Lingeng Lu; Lizhu Lin
Journal:  Sci Rep       Date:  2021-04-21       Impact factor: 4.379

2.  Fine Mapping of the MHC Region Identifies Novel Variants Associated with HBV-Related Hepatocellular Carcinoma in Han Chinese.

Authors:  Haoming Mai; Jiaxuan Chen; Haitao Chen; Zhiwei Liu; Guanlin Huang; Jialin Wang; Qianyi Xiao; Weihua Ren; Bin Zhou; Jinlin Hou; Deke Jiang
Journal:  J Hepatocell Carcinoma       Date:  2021-08-16

Review 3.  Evolving Treatment of Advanced Hepatocellular Carcinoma in the Asia-Pacific Region: A Review and Multidisciplinary Expert Opinion.

Authors:  Sadahisa Ogasawara; Su-Pin Choo; Jiang-Tao Li; Changhoon Yoo; Bruce Wang; Dee Lee; Pierce K H Chow
Journal:  Cancers (Basel)       Date:  2021-05-27       Impact factor: 6.639

4.  Drug-Target Interaction Network Analysis of Gene-Phenotype Connectivity Maintained by Genistein.

Authors:  Baoshan Li; Yi Jiang; Jingxin Chu; Qian Zhou
Journal:  J Comput Biol       Date:  2020-04-16       Impact factor: 1.479

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.